Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-09-08 Purchase |
2020-09-08 8:01 pm |
VYNE Therapeutics Inc. | VYNE | Saik Andrew Chief Financial Officer |
40,000 | $1.462 | $58,480 | 340,000 (Direct) |
View |
| 2020-09-08 Purchase |
2020-09-08 8:00 pm |
VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO |
75,000 | $1.3809 | $103,568 | 1,315,966 (Direct) |
View |
| 2020-06-09 Purchase |
2020-06-11 7:33 pm |
Menlo Therapeutics Inc. | MNLO | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
2,702,702 | $1.85 | $4,999,999 | 22,876,410 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-08-20 Exercise |
2020-08-21 5:00 pm |
N/A 2029-05-16 |
Menlo Therapeutics Inc. | MNLO | BARBARI SHARON Director |
75,000 | $0 | 88,971 (Direct) |
View |
| 2020-08-20 Exercise |
2020-08-21 5:00 pm |
N/A N/A |
Menlo Therapeutics Inc. | MNLO | BARBARI SHARON Director |
75,000 | $1.48 | 88,971 (Direct) |
View |
| 2020-08-03 Option Award |
2020-08-05 4:41 pm |
N/A 2030-08-03 |
Menlo Therapeutics Inc. | MNLO | Bright Rex Director |
22,500 | $0 | 22,500 (Direct) |
View |
| 2020-08-03 Option Award |
2020-08-05 4:39 pm |
N/A 2030-08-03 |
Menlo Therapeutics Inc. | MNLO | Sandoval Elisabeth Director |
22,500 | $0 | 22,500 (Direct) |
View |
| 2020-08-03 Option Award |
2020-08-05 4:39 pm |
N/A 2030-08-03 |
Menlo Therapeutics Inc. | MNLO | Bruno Anthony D Director |
22,500 | $0 | 22,500 (Direct) |
View |
| 2020-08-03 Option Award |
2020-08-05 4:38 pm |
N/A 2030-08-03 |
Menlo Therapeutics Inc. | MNLO | Basta Steven L Director |
22,500 | $0 | 22,500 (Direct) |
View |
| 2020-08-03 Option Award |
2020-08-05 4:37 pm |
N/A 2030-08-03 |
Menlo Therapeutics Inc. | MNLO | BARBARI SHARON Director |
22,500 | $0 | 22,500 (Direct) |
View |
| 2020-06-30 Tax Withholding |
2020-07-02 4:25 pm |
N/A N/A |
Menlo Therapeutics Inc. | MNLO | Wiley Matthew T. Chief Commercial Officer |
1,541 | $1.73 | 352,425 (Direct) |
View |
| 2020-06-30 Tax Withholding |
2020-07-02 4:25 pm |
N/A N/A |
Menlo Therapeutics Inc. | MNLO | Stuart Iain Chief Scientific Officer |
2,378 | $1.73 | 291,018 (Direct) |
View |
| 2020-06-30 Tax Withholding |
2020-07-02 4:24 pm |
N/A N/A |
Menlo Therapeutics Inc. | MNLO | Harsch Mutya Chief Legal Officer and GC |
1,822 | $1.73 | 318,887 (Direct) |
View |
| 2020-06-30 Tax Withholding |
2020-07-02 4:22 pm |
N/A N/A |
Menlo Therapeutics Inc. | MNLO | Domzalski David President and CEO |
6,239 | $1.73 | 1,240,966 (Direct) |
View |
| 2020-05-06 Option Award |
2020-05-08 5:54 pm |
N/A 2030-05-06 |
Menlo Therapeutics Inc. | MNLO | Wiley Matthew T. Chief Commercial Officer |
150,000 | $0 | 503,967 (Direct) |
View |
| 2020-05-06 Option Award |
2020-05-08 5:54 pm |
N/A 2030-05-06 |
Menlo Therapeutics Inc. | MNLO | Stuart Iain Chief Scientific Officer |
112,500 | $0 | 405,901 (Direct) |
View |
| 2020-05-06 Option Award |
2020-05-08 5:54 pm |
N/A 2030-05-06 |
Menlo Therapeutics Inc. | MNLO | Saik Andrew Chief Financial Officer |
250,000 | $0 | 550,000 (Direct) |
View |
| 2020-05-06 Option Award |
2020-05-08 5:53 pm |
N/A 2030-05-06 |
Menlo Therapeutics Inc. | MNLO | Harsch Mutya Chief Legal Officer and GC |
150,000 | $0 | 470,712 (Direct) |
View |
| 2020-05-06 Option Award |
2020-05-08 5:53 pm |
N/A 2030-05-06 |
Menlo Therapeutics Inc. | MNLO | Domzalski David President and CEO |
680,000 | $0 | 1,927,213 (Direct) |
View |